Authors
Yongtai Bai, Zhe Zhou, Xueqing Yan, Xin Li, Yuyang Dong, Tingyang Zhou, Ye Xiao, Manfei Si, Qiang Liu, Jingying Peng, Chengqi Yi
Published in
Molecular cell. Oct 13, 2026. Epub Oct 13, 2026.
Abstract
The current paradigm of N6-methyladenosine (m6A) homeostasis is implemented by a "writer/eraser/reader" system. Whether or not signaling pathways may regulate m6A homeostasis remains unclear. Here, we identify a negative feedback mechanism between m6A reader IGF2BPs and writer METTL3/METTL14 in human cell lines, which is orchestrated by poly(ADP-ribose) polymerase 1 (PARP1)-catalyzed ADP ribosylation. Specifically, IGF2BPs recruit PARP1 to m6A-modified RNAs and stimulate PARP1 activity; the m6A writer METTL3/14 is then ADP ribosylated, which impairs its RNA-binding capability and reduces m6A deposition. Based on the "read-orchestrate-write" mechanism, we combined PARP inhibitor (PARPi) therapy and m6A-targeting strategies (by inhibiting IGF2BP2 or METTL3) and observed synergistic anti-tumor effects. Taken together, this work expands our understanding of the regulatory paradigm of m6A methylation and provides an opportunity to exploit these findings for cancer therapy.
PMID:
42869010
Bibliographic data and abstract were imported from PubMed on 14 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0